Evidence map›Paper›PMID 29255264›Full record

ArticleNature genetics2018

Identification of H3K4me1-associated proteins at mammalian enhancers.

Andrea Local, Hui Huang, Claudio P Albuquerque, Namit Singh, Ah Young Lee, Wei Wang, Chaochen Wang, Judy E Hsia, Andrew K Shiau, Kai Ge and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 149 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 2 syntheses or guidelines pooled it, 244 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. ELF5-Mediated Enhancer-Promoter Interaction Regulates LALBA Expression in Ovine Mammary Gland.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Enhancer regulation in cancer: from epigenetics to mArchives of pharmacal research · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Andrea Local *Ludwig Institute for Cancer Research, La Jolla, CA, USA.
Hui Huang *Ludwig Institute for Cancer Research, La Jolla, CA, USA.
Claudio P AlbuquerqueLudwig Institute for Cancer Research, La Jolla, CA, USA.
Namit SinghLudwig Institute for Cancer Research, La Jolla, CA, USA.
Ah Young LeeLudwig Institute for Cancer Research, La Jolla, CA, USA.
Wei WangSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA.
Chaochen WangSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA.
Judy E HsiaLudwig Institute for Cancer Research, La Jolla, CA, USA.
Andrew K ShiauLudwig Institute for Cancer Research, La Jolla, CA, USA.
Kai GeNational Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health, Bethesda, MD, USA.
Kevin D CorbettLudwig Institute for Cancer Research, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-5854-2388
Dong WangSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-2829-1546
Huilin ZhouLudwig Institute for Cancer Research, La Jolla, CA, USA.
Bing RenLudwig Institute for Cancer Research, La Jolla, CA, USA. biren@ucsd.edu.ORCID http://orcid.org/0000-0002-5435-1127
Ludwig Cancer Research · USUniversity of California San Diego · USLudwig Cancer Research · BENational Institutes of Health · US

Funding

Regulation of PPARgamma Expression and Adipogenesis by PTIP-Associated FactorsZIADK075003 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI GE, KAI · 2009 to 2025
$17.6M
Contemporary Approaches to Cancer Cell Signaling and CommunicationT32CA009523 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DONOGHUE, DANIEL J, YANG, JING · 1985 to 2025
$12.1M
Molecular Mechanisms for DNA Damage Processing by Transcription MachineryR01GM102362 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WANG, DONG · 2013 to 2025
$5.6M
Suppression of duplication-mediated genome rearrangements by protein sumoylationR01GM116897 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHOU, HUILIN · 2015 to 2023
$2.6M
Systems-wide analysis of histone lysine 2-hydroxyisobutyrylation pathwayR01GM115961 · NIGMS · UNIVERSITY OF CHICAGO · PI ZHAO, YINGMING · 2016 to 2019
$1.8M
Regulation and functions of DNA damage checkpoint kinases in YeastR01GM080469 · NIGMS · LUDWIG INSTITUTE FOR CANCER RES LTD · PI ZHOU, HUILIN · 2007 to 2011
$1.4M
Technology for the Analysis of Protein PhosphorylationK22HG002604 · NHGRI · LUDWIG INSTITUTE FOR CANCER RESEARCH · PI ZHOU, HUILIN · 2002 to 2005
$1.1M
Regulation of Receptor Tyrosine KinasesR01GM065490 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI DONOGHUE, DANIEL J · 2002 to 2005
$1.0M
Orbitrap Fusion Mass SpectrometerS10OD023498 · OD · LUDWIG INSTITUTE FOR CANCER RES LTD · PI ZHOU, HUILIN · 2017 to 2017
$600k
NCI NIH HHS T32 CA009523NHGRI NIH HHS K22 HG002604NIGMS NIH HHS R01 GM065490NIGMS NIH HHS R01 GM080469NIGMS NIH HHS R01 GM102362NIGMS NIH HHS R01 GM115961NIGMS NIH HHS R01 GM116897NIH HHS S10 OD023498
6 · The paper itself

Abstract

Enhancers act to regulate cell-type-specific gene expression by facilitating the transcription of target genes. In mammalian cells, active or primed enhancers are commonly marked by monomethylation of histone H3 at lysine 4 (H3K4me1) in a cell-type-specific manner. Whether and how this histone modification regulates enhancer-dependent transcription programs in mammals is unclear. In this study, we conducted SILAC mass spectrometry experiments with mononucleosomes and identified multiple H3K4me1-associated proteins, including many involved in chromatin remodeling. We demonstrate that H3K4me1 augments association of the chromatin-remodeling complex BAF to enhancers in vivo and that, in vitro, H3K4me1-marked nucleosomes are more efficiently remodeled by the BAF complex. Crystal structures of the BAF component BAF45C indicate that monomethylation, but not trimethylation, is accommodated by BAF45C's H3K4-binding site. Our results suggest that H3K4me1 has an active role at enhancers by facilitating binding of the BAF complex and possibly other chromatin regulators.

Indexed as

Enhancer Elements, GeneticHistone CodeAnimalsCell LineChromatinChromatin Assembly and DisassemblyHeLa CellsHistonesHumansLysineMiceNuclear ProteinsNucleosomesProtein BindingChromatinHistonesLysineNuclear ProteinsNucleosomes

Identifiers

PMID29255264
PMCPMC6007000
OpenAlexW2774699268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.